Determination of Fluvastatin Sodium in Plasma: Application to Pharmacokinetics

HE Min;WNG Xing-jun;YO Tong-wei

Chinese Pharmaceutical Journal ›› 2006, Vol. 41 ›› Issue (02) : 132-134.

Chinese Pharmaceutical Journal ›› 2006, Vol. 41 ›› Issue (02) : 132-134.
论著

Determination of Fluvastatin Sodium in Plasma: Application to Pharmacokinetics

  • HE Min,WANG Xiang-jun,YAO Tong-wei
Author information +
History +

Abstract

OBJECTIVE To establish a HPLC method for the determination of fluvastatin sodium in plasma and to investigate its pharma-cokinetic characteristics in Beagle dogs.METHODS The plasma was mixed with the same volume of KH2PO4 buffer (pH 2) . Fluvastatin was extracted from plasma with ether. The content of fluvastatin in plasma was detected by fluorescence detector at λex 305 nm,λem 390 nm with the DiamonsilTM C18(4.6 mm×200 mm,5 μm)column. The mobile phase consisted of methol-10 mmol·L-1 KH2PO4(adjusted to pH2 with H3PO4) (75:25) at a flow rate of 1.0 mL·min-1. The data obtained was processed with 3P87 program for pharmacokinetic parameters.RESULTS The linear range was 20.16~5 040.0 μg·L-1(r=0.999 8). The lowest detectable concentration was 5.04 μg·L-1(S/N=3). The average method recovery was 93.30%~102.9% , and extracted recovery was over 90% for the low, middle, high control sample. The relative standard deviations obtained for inter-and intra-assay precisions were less than 5% .CONCLUSION This method is convenient, sensitive and reproducible, and is suitable for the determination of fluvastatin sodium concentration in plasma for pharmacokinetic studies.

Key words

fluvastatin / HPLC / pharmacokinetics

Cite this article

Download Citations
HE Min;WNG Xing-jun;YO Tong-wei. Determination of Fluvastatin Sodium in Plasma: Application to Pharmacokinetics [J]. Chinese Pharmaceutical Journal, 2006, 41(02): 132-134

References

[1] PAOLETTI R,CORSINI A,BELLOSTA S. Pharmacological interactions of statins[J] .Atherosclerosis,2002,3(1): 35-40. [2] CORSINI A, BELLOSTA S,BEATEA R,et al.New insights into the pharmacodynamic and pharmacokinetic properties of statins[J] . Pharmacol Ther,1999,84(3): 413-428. [3] ISAACSOHN J L,LASALLE J,CHAO G,et al. Comparison of treatment with fluvastatin extended-release 80 mg tablets and immediate-release 40 mg capsules in patients with primary hypercholesterolemia[J] .Clin Ther,2003,25(3):904-918. [4] NAKASHIMA A, SAXER C,NIINA M,et al. Determination of fluvastatin and its five metabolites in human plasma using simple gradient reversed-phase high-performance liquid chromatography with ultraviolet detection[J] . J Chromatogr B,2001,760(1):17-25. [5] LANCHOTE V L,ROCHA A,ALBUQUERQUE F U,et al. Stereoselective analysis of fluvastatin in human plasma for pharmacokinetic studies[J] .J Chromatogr B,2001,765(1):81-88. [6] AL-RAWITHI S, HUSSEIN R F, ALZAHRANI A. Sensitive assay for the determination of fluvastatin in plasma utilizing high-performance liquid chromatography with fluorescence detection[J] .Ther Drug Monit,2003,25(1):88-92.

Accesses

Citation

Detail

Sections
Recommended

/